Stomach Cancer Climbs to 28,000 Cases in US: AscellaHealth Provides High-Touch Specialty Pharmacy Solutions to Optimize Outcomes
BERWYN, Pa.--(BUSINESS WIRE)--Nov 4, 2019--
In recognition of Stomach Cancer Awareness Month in November, AscellaHealth, a specialty pharmacy benefit manager (SPBM), serving commercial, Medicare and Medicaid segments, points to the need for greater awareness and knowledge about the importance of earlier detection of stomach cancer and research for treatments to improve survival rates. There were approximately 28,000 cases of stomach cancer in the United States in 2019.
“AscellaHealth’s innovative specialty pharmacy strategy features clinical interventions, adherence counseling, psychosocial assessment, integrated nursing staff, refill reminders and delivery coordination designed to enhance the patient experience and improve outcomes,” says Dea Belazi, president and CEO, AscellaHealth. “As part of the significant value we create for members struggling with this serious illness, our high-touch model results in better care coordination and offers discounted pricing on specialty drugs.”
According to the American Society of Clinical Oncology, the total mean monthly cost of care for a newly diagnosed gastric cancer patient in the first year, including hospitalization, doctor visits, lab fees, radiology and drugs, was more than $10,600 per month.
AscellaHealth empowers health plans, employer groups and unions to overcome the challenges of cancer among plan members by offering Clinical and Educational Programs. Designed to educate members on their prescribed therapy beginning day one, these programs assist with high deductible/co-insurance costs by utilizing financial assistance programs and partnering with physicians and pharmacist throughout the member’s course of treatment.
AscellaHealth’s program is available on a standalone basis, or as part of a full-service pharmacy benefit management option that includes specialty drug management, formulary management services/rebates, competitive pricing and innovative discounting, drug utilization review, case management services/therapy management, clinical review/prior authorization, pharmacy and therapeutic management committee, flexible claims adjudication system, drug information and news reporting.
“As a specialty-focused pharmaceutical management company, we urge stakeholders to consider how our custom benefit designs can improve patient outcomes and quality of life for members living with stomach cancer,” Belazi adds.
AscellaHealth, a specialty pharmacy benefit manager (SPBM), serving commercial, Medicare and Medicaid segments, offers high quality prescription drug benefit management services. Complemented by other customizable services, such as carved-out specialty pharmacy services and cost-savings programs, AscellaHealth provides a unique, proprietary service portfolio. Visit www.ascellahealth.com.
View source version on businesswire.com:https://www.businesswire.com/news/home/20191104005069/en/
CONTACT: Nicole Dufour
201.641.1911 x 54
KEYWORD: PENNSYLVANIA UNITED STATES NORTH AMERICA
INDUSTRY KEYWORD: HEALTH RADIOLOGY PHARMACEUTICAL MANAGED CARE ONCOLOGY
Copyright Business Wire 2019.
PUB: 11/04/2019 10:00 AM/DISC: 11/04/2019 10:00 AM